On February 9, 2026, Stereotaxis revealed the introduction of a new robotic electrophysiology initiative at Klinikum Fürth in Fürth, Germany. As a groundbreaking company renowned for its surgical robotics in minimally invasive endovascular procedures, Stereotaxis operates on the NYSE under the ticker symbol STXS.